Skip to Main Content
Laurentiu Pop, M.D.

Laurentiu Pop, M.D.

Assistant Professor

School
Medical School
Department
Radiation Oncology
  • Biography

    Certified Principal Investigator by Academy of Clinical Research Professionals (2017)

    American Board of Medical Laboratory Immunology Diplomate (2013)

    Residency University of Medicine and Pharmacy, Craiova, Romania, Oncology (2000)

    Graduate School University of Craiova, Romania, Medicine (1993)

  • Education
    Medical School
    University of Craiova Medical (1993), Medicine
  • Research Interest
    • Angiogenesis as a target for cancer therapy
    • B and T regulatory cells
    • Catabolism of immunoglobulins
    • Clinical research in oncology
    • Engineering monoclonal antibodies and immunoconjuates for cancer therapy
    • Immunogenic effect of heavy particle radiation
    • Immunomodulatory effect of radiation therapy
    • Innnate immunity DNA-sensing pathways
    • Mineral metabolism
    • Multidrug resistance in cancer therapy
    • Obesity, inflammation and cancer
    • Pancreatic cancer stem cells
    • Pathophysiology of glomerular filtration
    • Tumor dormancy
    • Type 1 and 2 diabetes
    • Vaccinology
  • Publications
    Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles
    Yaman S, Ramachandramoorthy H, Iyer P, Chintapula U, Nguyen T, Sabnani M, Kotadia T, Ghaffari S, Pop LM, Hannan R, Weidanz JA, Nguyen KT Bioactive Materials 2024 Apr 34 422-435
    Radiation-Induced Innate Neutrophil Response in Tumor Is Mediated by the CXCLs/CXCR2 Axis
    Zhang F, Mulvaney O, Salcedo E, Manna S, Zhu JZ, Wang T, Ahn C, Pop LM, Hannan R Cancers 2023 Dec 15
    Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer
    Hannan R, McLaughlin MF, Pop LM, Pedrosa I, Kapur P, Garant A, Ahn C, Christie A, Zhu J, Wang T, Robles L, Durakoglugil D, Woldu S, Margulis V, Gahan J, Brugarolas J, Timmerman R, Cadeddu J European urology 2023 Sep 84 275-286
    Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors
    Mundra V, Yang Y, von Itzstein MS, Fattah F, Gonugunta AS, Hannan R, Pop LM, Zhang Y, Wang Y, Sheffield T, Xie Y, Dowell JE, Homsi J, Rashdan S, Park J, Li Q, Wakeland EK, Gerber DE Translational Oncology 2023 Aug 34
    Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
    Hannan R, Dohopolski MJ, Pop LM, Mannala S, Watumull L, Womack KB, Gao A, Garant A, Arriaga YE, Bowman I, Chung J, Wang J, Ariizumi K, Ahn C, Timmerman R, Courtney K Biomedicines 2022 Jun 10
    Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma
    Hannan R, Mohamad O, Diaz De Leon III A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga YE, Courtney K, Cantarel B, Wakeland EK, Fu Y, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J Clinical Cancer Research 2021 Dec 27 6716-6725
    Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes
    Ding LH, Yu Y, Edmondson EF, Weil MM, Pop LM, McCarthy M, Ullrich RL, Story MD Scientific reports 2021 Dec 11
    Renal lipid metabolism abnormalities in obesity and clear cell renal cell carcinoma
    Bobulescu IA, Pop LM, Mani C, Turner K, Rivera C, Khatoon S, Kairamkonda S, Hannan R, Palle K Metabolites 2021 Sep 11
    Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade
    Moore C, Hsu CC, Chen WM, Chen BP, Han C, Story M, Aguilera T, Pop LM, Hannan R, Fu YX, Saha D, Timmerman R International Journal of Radiation Oncology Biology Physics 2021 Aug 110 1306-1316
    Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus—Safety Lead-in Results of a Phase 2 Trial
    Margulis V, Freifeld Y, Pop LM, Manna S, Kapur P, Pedrosa I, Christie A, Mohamad O, Mannala S, Singla N, Wait M, Bagrodia A, Woldu SL, Gahan J, Brugarolas J, Timmerman R, Hannan R International Journal of Radiation Oncology Biology Physics 2021 Jul 110 1135-1142
  • Books

    Featured 

  • Professional Associations/Affiliations
    • American Association of Immunologists (2005)
    • American Diabetes Association (2016)
    • American Society for Microbiology (2010)
    • Association of Clinical Research Professionals (2017)